{"id":13369,"date":"2024-08-23T00:43:59","date_gmt":"2024-08-22T22:43:59","guid":{"rendered":"https:\/\/valintermed.com\/?p=13369"},"modified":"2024-08-23T00:45:41","modified_gmt":"2024-08-22T22:45:41","slug":"rak-uroteliya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/urothelial-cancer\/","title":{"rendered":"Urothelial cancer"},"content":{"rendered":"
<\/div>\n

Urothelial cancer, or urothelial carcinoma, is a malignant neoplasm originating from the urothelial cells lining the bladder, ureters, and part of the urethra. This disease is characterized by a variety of clinical manifestations and can range from superficial forms that have a high chance of a favorable outcome after primary treatment, to invasive and metastatic variants. Urothelial carcinoma is the second most common cancer of the urinary system, and although it is more common in men, the proportion of women suffering from this disease is also noticeably increasing. Given the multifactorial nature of this cancer, understanding its features is critical for timely diagnosis and effective treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n